Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ By Ogkologos - January 8, 2025 841 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the COMET study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Welcomes the WHO Global Status Report on Cancer with Key Recommendations for Equitable Cancer Care Lorlatinib Continues to Show Long-Term Benefit in Newly-Diagnosed Patients with Advanced ALK-positive NSCLC GLP-1 Receptor Agonist Use Associated with a Significantly Lower Short-Term Incidence of Obesity-Associated Cancers Among Obese Individuals Without Diabetes MOST POPULAR How to Safely Keep Up With Your Cancer Screening and Care... December 10, 2020 OncoArray Links Dozens of DNA Variants to Risk for Common Cancers June 12, 2018 2023 ASCO Annual Meeting Research Round Up: Advances in Treating Gynecologic... August 17, 2023 Molecular Analysis for Precision Oncology Congress 2022, 14-16 October 2022, Amsterdam,... September 29, 2022 Load more HOT NEWS FDA Approves Acalabrutinib with Bendamustine and Rituximab for Previously Untreated Mantle... Italian Association of Oncology Nurses Maps the Situation of Cancer Patients... Five Questions With…Francisco. Adjuvant Abemaciclib Combined with Endocrine Therapy Improves IDFS in HR-Positive, HER2−Negative,...
